Climate Change May Promote the Global Spread of Arboviruses Climate Change May Promote the Global Spread of Arboviruses
Arboviruses such as chikungunya, dengue, and Zika are being detected in new regions that are ill prepared to confront them.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 28, 2023 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
Luis Cuevas obituary
My longtime colleague Luis Cuevas, who has died aged 66 of pancreatic cancer, was an academic who specialised in paediatrics, epidemiology and tropical medicine. For most of his career he did his research and teaching at theLiverpool School of Tropical Medicine (LSTM), which he joined in 1985 after fleeing to the UK from political violence in his native Guatemala. He was still working at the LSTM at his death.Luis ’s work focused mainly on the diagnosis and management of diseases of poverty, and one of his most notable achievements was the development of a same-day diagnosis approach for tuberculosis, which was adopted b...
Source: Guardian Unlimited Science - February 24, 2023 Category: Science Authors: Bertie Squire Tags: Medical research Medicine Guatemala Liverpool Tuberculosis Hospitals World Health Organization Source Type: news
Mauritius: Using Sterile Insect Technique to Mitigate Mosquito Proliferation
[Government of Mauritius] Mauritius currently being in the rainy season, which favours the proliferation of mosquitoes in several regions around the island, the Vector Biology and Control Division is presently implementing a Sterile Insect Technique (SIT) project which forms part of the integrated vector management strategy to tackle mosquito-borne illnesses such as dengue and chikungunya. This Division operates under the aegis of the Ministry of Health and Wellness. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 3, 2023 Category: African Health Source Type: news
Valneva Completes BLA Submission to U.S. FDA for its Single-Shot Chikungunya Vaccine Candidate
Saint-Herblain (France), December 23, 2022– Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces that it has completed rolling submission of the Biologics License Application (BLA) to the U.S. Food and... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - December 23, 2022 Category: Drugs & Pharmacology Source Type: news
Mysterious ancient humans may have given people of Papua New Guinea an immune advantage
When modern humans first migrated from Africa to the tropical islands of the southwest Pacific, they encountered unfamiliar people and new pathogens. But their immune systems may have picked up some survival tricks when they mated with the locals—the mysterious
Denisovans
who gave them immune gene variants that might have protected the newcomers’ offspring from local diseases. Some of these variants still persist in the genomes of people living in Papua New Guinea today, according to a new study.
Researchers have known for a decade that living people in Papua New Guinea and other parts of Melanesia, a s...
Source: ScienceNOW - December 8, 2022 Category: Science Source Type: news
CDC: Advisory Committee on Immunization Practices (ACIP)
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) is hosting a virtual meeting on October 19-20, 2022. The agenda will include discussions on influenza vaccines, pneumococcal vaccine, meningococcal vaccines, respiratory syncytial virus vaccine, rotavirus vaccine, dengue vaccines, adult immunization schedule, child/adolescent immunization schedule, COVID-19 vaccines, and Chikungunya vaccine. Includes information on how to submit public comments or request permission to make a public comment during the meeting. Registration is not required, and the meeting is open to the...
Source: Federal Register updates via the Rural Assistance Center - September 16, 2022 Category: Rural Health Source Type: news
ICMR-VCRC develop special bacteria-infected mosquitoes to control dengue, chikungunya viruses
(Source: The Economic Times)
Source: The Economic Times - July 7, 2022 Category: Consumer Health News Source Type: news
Africa: Viruses Can Change Your Scent to Make You More Attractive to Mosquitoes, New Research Finds
[The Conversation Africa] Mosquitoes are the world's deadliest animal. Over 1 million deaths per year are attributed to mosquito-borne diseases, including malaria, yellow fever, dengue fever, Zika and chikungunya fever. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 1, 2022 Category: African Health Source Type: news
Warning: Climate Crisis Is Now the Single Biggest Health Threat Facing Humanity
This year’s World Health Day launched a new warning: more than 13 million deaths around the world each year are due to “avoidable environmental causes”. Credit: BigstockBy Baher KamalMADRID, Apr 5 2022 (IPS) While the world’s top scientists and experts continue their arduous work to finally submit to politicians at the 27th session of the Conference of the Parties (COP 27) in Sharm El-Sheikh, Egypt (7-18 November 2022), a new alert now emerges: the climate crisis has already become the single biggest health threat to humankind.
But this new alert should be no surprise: it rather constitutes the logic, expected cons...
Source: IPS Inter Press Service - Health - April 5, 2022 Category: International Medicine & Public Health Authors: Baher Kamal Tags: Development & Aid Environment Global Headlines Health TerraViva United Nations World Health Day Source Type: news
Moderna Is Sharing Its Vaccine Technology With Low-Income Countries. But That Doesn ’t Mean Locally Produced Shots Are Coming Soon
Moderna, the Massachusetts-based company behind one of the two mRNA COVID-19 vaccines, made the decision in 2020 not to enforce the patent on its shot. The move was meant to encourage low- and middle-income countries that couldn’t afford to purchase billions of doses of the vaccine (as the U.S., Canada, and many European countries had done) to develop their own versions of the shot using less expensive resources.
On Mar. 8, Moderna went a step further, saying that it will now extend that promise indefinitely in the 92 low- and middle-income countries that are receiving doses from COVAX, the global vaccine distributio...
Source: TIME: Health - March 9, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Fighting Dengue Virus with Biological Weapons
Dr Ijaz Ali has spent the last 11 years persuading the authorities to use genetically engineered mosquitoes to fight dengue fever. The health department, however, is concerned about unforeseen circumstances that could arise from this method. By Zofeen EbrahimKarachi , Nov 2 2021 (IPS) Twenty-three-year-old Sarah Tajammal felt a sense of “impending doom” as she fought high fever, nausea, bouts of vomiting and extreme fatigue after being diagnosed with dengue two weeks back.
Living in Lahore’s DHA area, which has reported the most dengue cases “because of the damp green environment”, she may have caught it at home...
Source: IPS Inter Press Service - Health - November 2, 2021 Category: International Medicine & Public Health Authors: Zofeen Ebrahim Tags: Asia-Pacific Development & Aid Environment Featured Headlines Health Human Rights Humanitarian Emergencies Inequity TerraViva United Nations Source Type: news
Collaborative COVID-19 lockdown effort delivers major boost for vaccine innovation in Bristol
Faster vaccine development could be a step closer thanks to £ 4 million investment to Imophoron Ltd, a Bristol University biotech start-up developing a novel, next generation rapid-response vaccine platform called ADDomer ™ . Imophoron will use the investment to bring ADDomer vaccines to clinical stage, initially targeting three viruses, RSV (respiratory syncytial virus), COVID-19, and mosquito-borne Chikungunya. (Source: University of Bristol news)
Source: University of Bristol news - October 7, 2021 Category: Universities & Medical Training Tags: Announcements, Business and Enterprise, Grants and Awards, Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Life Sciences, Faculty of Life Sciences, School of Biochemistry, Faculty Source Type: news
Bharat Biotech, IVI launch Chikungunya Vaccine Phase 2/3 trial in Costa Rica
CEPI first partnered with IVI and Bharat Biotech in June 2020, providing up to USD 14.1 million for vaccine manufacturing and clinical development of the BBV87 vaccine candidate. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 25, 2021 Category: Pharmaceuticals Source Type: news
Zika virus case reported in India: Symptoms, treatment & other key things to know
Zika virus is spread by Aedes aegypti — the same mosquito that is also responsible for causing dengue and chikungunya. The virus is considered a huge cause for worry for pregnant women because it causes microcephaly, a birth defect. (Source: The Economic Times)
Source: The Economic Times - July 9, 2021 Category: Consumer Health News Source Type: news
